Literature DB >> 27982478

A Mendelian Randomization Study of the Effect of Type-2 Diabetes and Glycemic Traits on Bone Mineral Density.

Omar S Ahmad1,2, Aaron Leong3, Julie Ann Miller1, John A Morris1, Vincenzo Forgetta1, Muhammad Mujammami1,4, J Brent Richards1,2,5.   

Abstract

Type-2 diabetes (T2D) is associated in observational studies with both higher bone mineral density (BMD) and higher fracture risk for given BMD. These relationships may however be confounded by factors such as body mass index (BMI). Here we used Mendelian randomization (MR) to obtain non-confounded estimates of the effect of T2D and glycemic traits on BMD. We identified genetic variants strongly associated with T2D risk (34,840 T2D cases and 114,981 controls) and fasting glucose (133,010 nondiabetic individuals), but not associated with BMI, and determined the effects of these variants on BMD (up to 83,894 individuals). Using these variants as instrumental variables, we found that a genetically-increased risk of T2D increased femoral neck BMD (+0.034 SD in BMD per unit increase in log-odds of T2D [95% CI, 0.001 to 0.067; p = 0.044]). Genetically-increased fasting glucose also increased femoral neck BMD (+0.13 SD in BMD per mmol/L increase in fasting glucose [95% CI, 0.01 to 0.25; p = 0.034]). Similar nonsignificant trends were observed for the effects of T2D and fasting glucose on lumbar spine BMD. Our results indicate that both genetically-increased T2D risk and genetically-increased fasting glucose have weak positive effects on BMD.
© 2016 American Society for Bone and Mineral Research. © 2016 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE MINERAL DENSITY; DIABETES; HUMAN ASSOCIATION STUDES; OSTEOPOROSIS

Mesh:

Substances:

Year:  2017        PMID: 27982478     DOI: 10.1002/jbmr.3063

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

1.  Effect of Insulin Resistance on BMD and Fracture Risk in Older Adults.

Authors:  Nicola Napoli; Caterina Conte; Claudio Pedone; Elsa S Strotmeyer; Kamil E Barbour; Dennis M Black; Elizabeth J Samelson; Ann V Schwartz
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

2.  Genetically driven adiposity traits increase the risk of coronary artery disease independent of blood pressure, dyslipidaemia, glycaemic traits.

Authors:  Wan-Qiang Lv; Xue Zhang; Kun Fan; Xin Xia; Qiang Zhang; Hui-Min Liu; Bu-Ying Jiang; Wei-Dong Zhang; Hong-Wen Deng
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

3.  Increasing fasting glucose and fasting insulin associated with elevated bone mineral density-evidence from cross-sectional and MR studies.

Authors:  H Zhou; C Li; W Song; M Wei; Y Cui; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2021-01-06       Impact factor: 4.507

4.  Genetically Predicted Sex Hormone-Binding Globulin and Bone Mineral Density: A Mendelian Randomization Study.

Authors:  Zihao Qu; Jiuzhou Jiang; Fangkun Yang; Jiawei Huang; Jianqiang Zhao; Shigui Yan
Journal:  Calcif Tissue Int       Date:  2020-10-17       Impact factor: 4.333

Review 5.  Diabetes, bone and glucose-lowering agents: clinical outcomes.

Authors:  Ann V Schwartz
Journal:  Diabetologia       Date:  2017-04-27       Impact factor: 10.122

6.  Greater Carboxy-Methyl-Lysine Is Associated With Increased Fracture Risk in Type 2 Diabetes.

Authors:  Ruban Dhaliwal; Susan K Ewing; Deepak Vashishth; Richard D Semba; Ann V Schwartz
Journal:  J Bone Miner Res       Date:  2021-11-24       Impact factor: 6.741

Review 7.  A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction.

Authors:  Jordi Merino; Miriam S Udler; Aaron Leong; James B Meigs
Journal:  Curr Diab Rep       Date:  2017-11-04       Impact factor: 4.810

Review 8.  Mendelian randomization in the bone field.

Authors:  Susanna C Larsson; Karl Michaëlsson; Stephen Burgess
Journal:  Bone       Date:  2018-10-12       Impact factor: 4.398

9.  Changes in the Bone Mineral Density of Femur Neck and Total Hip Over a 52-Week Treatment with Lobeglitazone.

Authors:  Da Young Lee; Ji A Seo
Journal:  Diabetes Metab J       Date:  2017-10       Impact factor: 5.376

10.  Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis.

Authors:  John P Kemp; John A Morris; Carolina Medina-Gomez; Vincenzo Forgetta; Nicole M Warrington; Scott E Youlten; Jie Zheng; Celia L Gregson; Elin Grundberg; Katerina Trajanoska; John G Logan; Andrea S Pollard; Penny C Sparkes; Elena J Ghirardello; Rebecca Allen; Victoria D Leitch; Natalie C Butterfield; Davide Komla-Ebri; Anne-Tounsia Adoum; Katharine F Curry; Jacqueline K White; Fiona Kussy; Keelin M Greenlaw; Changjiang Xu; Nicholas C Harvey; Cyrus Cooper; David J Adams; Celia M T Greenwood; Matthew T Maurano; Stephen Kaptoge; Fernando Rivadeneira; Jonathan H Tobias; Peter I Croucher; Cheryl L Ackert-Bicknell; J H Duncan Bassett; Graham R Williams; J Brent Richards; David M Evans
Journal:  Nat Genet       Date:  2017-09-04       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.